KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Sales (2016 - 2025)

Historic Return on Sales for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 0.22%.

  • Jazz Pharmaceuticals' Return on Sales rose 200.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of 0.14% for FY2024, which is 300.0% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Return on Sales is 0.22%, which was up 200.0% from 0.69% recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year Return on Sales high stood at 0.22% for Q3 2025, and its period low was 0.69% during Q2 2025.
  • For the 5-year period, Jazz Pharmaceuticals' Return on Sales averaged around 0.0%, with its median value being 0.08% (2023).
  • Its Return on Sales has fluctuated over the past 5 years, first skyrocketed by 5200bps in 2022, then tumbled by -8500bps in 2025.
  • Jazz Pharmaceuticals' Return on Sales (Quarter) stood at 0.04% in 2021, then tumbled by -584bps to 0.25% in 2022, then soared by 138bps to 0.09% in 2023, then skyrocketed by 88bps to 0.18% in 2024, then increased by 27bps to 0.22% in 2025.
  • Its last three reported values are 0.22% in Q3 2025, 0.69% for Q2 2025, and 0.18% during Q1 2025.